Neuland Laboratories Limited
Mahindra Manulife Mutual Fund increased its stake in Neuland Laboratories from 1.44% to 1.93%, buying 62,093 shares. Based on the current share price of ₹18,434.00, the value of the additional shares is approximately ₹114.46 lakh.
A pharmaceutical manufacturer engaged in the production and distribution of bulk drugs, Neuland Labs serves both domestic and international markets through its integrated operations. The company specializes in manufacturing active pharmaceutical ingredients and provides contract manufacturing services to global pharmaceutical companies. Its facilities are designed to meet stringent international quality and regulatory standards for pharmaceutical production.
Joint venture between Mahindra Group and Manulife Investment Management of Canada. Manages over Rs 30,000 crore. Focuses on equity and hybrid fund strategies with a quality growth bias inherited from the Manulife global investment framework. Leverages the Mahindra Group's brand and distribution reach for retail investor outreach.